Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Nearly half a century has passed since the demonstration that cannabis and its chief psychoactive component Δ9-THC lowers intraocular pressure (IOP).Elevated IOP remains the chief hallmark and therapeutic target for glaucoma, a condition that places millions at risk of blindness.It is likely SHAMPOO TWO that Δ9-THC exerts much of its IO